Enhancing global access to diabetes medicines: policy lessons from the HIV response.

Autor: Teufel F; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA; Emory Global Diabetes Research Center of the Woodruff Health Sciences Center and Emory University, Atlanta, GA, USA. Electronic address: felix.teufel@emory.edu., Bulstra CA; Health Systems Innovation Lab, Department of Global Health and Population, Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA; Heidelberg Institute of Global Health, Heidelberg University Medical Center, Heidelberg, Germany., Davies JI; Institute of Applied Health Research, University of Birmingham, Birmingham, UK; MRC/Wits Rural Public Health and Health Transitions Research Unit, Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa; Centre for Global Surgery, Department of Global Health, Stellenbosch University, Cape Town, South Africa., Ali MK; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA; Emory Global Diabetes Research Center of the Woodruff Health Sciences Center and Emory University, Atlanta, GA, USA; Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, GA, USA.
Jazyk: angličtina
Zdroj: The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2024 Feb; Vol. 12 (2), pp. 88-90. Date of Electronic Publication: 2023 Dec 18.
DOI: 10.1016/S2213-8587(23)00359-5
Abstrakt: Competing Interests: CAB was supported by the Dutch Research Council's Rubicon programme (project number 452022313). MKA reported a past grant from Merck & Co to Emory University and past consulting fees from Bayer and Eli Lilly and Company outside the scope of the submitted work. All other authors declare no competing interests.
Databáze: MEDLINE